impactCancer Summer 2015
At the Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James), we start with groundbreaking research and translate that to superb and compassionate patient care. Though our Comprehensive Cancer Center is 40 years old, it wasn’t until July 1990 that we opened The James – a hospital dedicated to helping cancer patients. It is on the 25th anniversary of the James that we reflect on the incredible research work we have done and, more importantly, the thousands of patients and families we have helped.
Everything we do—from preclinical laboratory research, to clinical trials involving patients, to population and prevention studies—is designed to improve the care that we offer to our patients and their families, thus enhancing their quality of life and renewing their hope for the future.
That’s why we spent nearly a decade carefully planning, designing and building our new 21-floor, 306-bed cancer hospital that opened last December as a transformational facility that places researchers and clinicians into closer working proximity than ever before so we can more quickly translate discoveries to improved treatments.
It’s also why each inpatient unit at the new James is dedicated to a particular type of cancer and contains teams of sub-specialists—including medical oncologists, surgical oncologists, radiation oncologists, nurses, pharmacists, genetic experts, pathologists and others—working together to develop and deliver effective targeted therapies tailored to each patient’s cancer. Dozens of these specialists have been recruited over the past several years as we continuously strive to bring the best and brightest minds in cancer care to Ohio State.
A story in this issue of impactCancer provides a closer look at our dedication to providing the best possible care for our patients and families throughout their cancer journey. Nothing is more important to our team.
Michael A. Caligiuri, MD
Director, The Ohio State University Comprehensive Cancer Center
CEO, James Cancer Hospital and Solove Research Institute